Reprimo methylation is a potential biomarkerof Barrett's-associated esophageal neoplastic progression

James P. Hamilton, Fumiaki Sato, Zhe Jin, Bruce D. Greenwald, Tetsuo Ito, Yuriko Mori, Bogdan C. Paun, Takatsugu Kan, Yulan Cheng, Suna Wang, Jian Yang, John M. Abraham, Stephen J. Meltzer

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Reprimo methylation is a potential biomarkerof Barrett's-associated esophageal neoplastic progression'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Keyphrases

Medicine and Dentistry